Vatiquinone + Placebo
Phase 2/3Completed 0 watching 0 views this week๐ Rising
62
Development Stage
โ
Pre-clinicalโ
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Friedreich Ataxia
Conditions
Friedreich Ataxia
Trial Timeline
Dec 17, 2020 โ Oct 2, 2023
NCT ID
NCT04577352About Vatiquinone + Placebo
Vatiquinone + Placebo is a phase 2/3 stage product being developed by PTC Therapeutics for Friedreich Ataxia. The current trial status is completed. This product is registered under clinical trial identifier NCT04577352. Target conditions include Friedreich Ataxia.
Hype Score Breakdown
Clinical
22
Activity
15
Company
7
Novelty
7
Community
8
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04577352 | Phase 2/3 | Completed |
Competing Products
20 competing products in Friedreich Ataxia